| Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells DI Gabrilovich, HL Chen, KR Girgis, HT Cunningham, GM Meny, S Nadaf, ... Nature medicine 2 (10), 1096-1103, 1996 | 3037 | 1996 |
| First-line nivolumab in stage IV or recurrent non–small-cell lung cancer DP Carbone, M Reck, L Paz-Ares, B Creelan, L Horn, M Steins, E Felip, ... New England Journal of Medicine 376 (25), 2415-2426, 2017 | 2481 | 2017 |
| ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers K Bergethon, AT Shaw, SH Ignatius Ou, R Katayama, CM Lovly, ... Journal of clinical oncology 30 (8), 863-870, 2012 | 1941 | 2012 |
| Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer B Almand, JI Clark, E Nikitina, J van Beynen, NR English, SC Knight, ... The Journal of Immunology 166 (1), 678-689, 2001 | 1726 | 2001 |
| Expansion of myeloid immune suppressor Gr+ CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis L Yang, LM DeBusk, K Fukuda, B Fingleton, B Green-Jarvis, Y Shyr, ... Cancer cell 6 (4), 409-421, 2004 | 1325 | 2004 |
| Overall survival and long-term safety of nivolumab (anti–programmed death 1 antibody, BMS-936558, ONO-4538) in patients with previously treated advanced non–small-cell lung cancer SN Gettinger, L Horn, L Gandhi, DR Spigel, SJ Antonia, NA Rizvi, ... Journal of clinical oncology 33 (18), 2004, 2015 | 1283 | 2015 |
| Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo … D Gabrilovich, T Ishida, T Oyama, S Ran, V Kravtsov, S Nadaf, ... Blood, The Journal of the American Society of Hematology 92 (11), 4150-4166, 1998 | 1255 | 1998 |
| Abrogation of TGFβ signaling in mammary carcinomas recruits Gr-1+ CD11b+ myeloid cells that promote metastasis L Yang, J Huang, X Ren, AE Gorska, A Chytil, M Aakre, DP Carbone, ... Cancer cell 13 (1), 23-35, 2008 | 1108 | 2008 |
| Clinical significance of defective dendritic cell differentiation in cancer B Almand, JR Resser, B Lindman, S Nadaf, JI Clark, ED Kwon, ... Clinical Cancer Research 6 (5), 1755-1766, 2000 | 986 | 2000 |
| First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open … L Paz-Ares, TE Ciuleanu, M Cobo, M Schenker, B Zurawski, J Menezes, ... The Lancet Oncology 22 (2), 198-211, 2021 | 969 | 2021 |
| NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway M Terabe, S Matsui, N Noben-Trauth, H Chen, C Watson, DD Donaldson, ... Nature immunology 1 (6), 515-520, 2000 | 880 | 2000 |
| Non-small-cell lung cancer C Gridelli, A Rossi, DP Carbone, J Guarize, N Karachaliou, T Mok, ... Nature reviews Disease primers 1 (1), 1-16, 2015 | 868 | 2015 |
| Proteomic patterns of tumour subsets in non-small-cell lung cancer K Yanagisawa, Y Shyr, BJ Xu, PP Massion, PH Larsen, BC White, ... The Lancet 362 (9382), 433-439, 2003 | 811 | 2003 |
| Delivering affordable cancer care in high-income countries R Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, ... The lancet oncology 12 (10), 933-980, 2011 | 796 | 2011 |
| Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-κB activation in hemopoietic progenitor cells T Oyama, S Ran, T Ishida, S Nadaf, L Kerr, DP Carbone, DI Gabrilovich The Journal of Immunology 160 (3), 1224-1232, 1998 | 723 | 1998 |
| Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine … RS Herbst, DH Johnson, E Mininberg, DP Carbone, T Henderson, ES Kim, ... Journal of Clinical Oncology 23 (11), 2544-2555, 2005 | 701 | 2005 |
| Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. I Chiba, T Takahashi, MM Nau, D D'Amico, DT Curiel, T Mitsudomi, ... Oncogene 5 (10), 1603-1610, 1990 | 676 | 1990 |
| Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC C Rolfo, PC Mack, GV Scagliotti, P Baas, F Barlesi, TG Bivona, RS Herbst, ... Journal of thoracic oncology 13 (9), 1248-1268, 2018 | 625 | 2018 |
| VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression JE Ohm, DI Gabrilovich, GD Sempowski, E Kisseleva, KS Parman, ... Blood 101 (12), 4878-4886, 2003 | 607 | 2003 |
| PDL1 Regulation by p53 via miR-34 MA Cortez, C Ivan, D Valdecanas, X Wang, HJ Peltier, Y Ye, L Araujo, ... Journal of the National Cancer Institute 108 (1), djv303, 2016 | 598 | 2016 |
